vida: extract claims from 2026-05-05-ozempic-personality-anhedonia-glp1-dopamine
- Factual accuracy — The claims appear factually correct, describing a potential side effect of GLP-1 agonists (anhedonia) and its implications, based on clinical observations and social…
vida: extract claims from 2026-05-05-npr-glp1-eating-disorders-not-well-understood
- Factual accuracy — The claims and entities appear factually correct, with evidence provided from reputable sources like NPR, PMC, and ANAD.
- Intra-PR duplicates — There are no…
vida: extract claims from 2026-05-05-ozempic-personality-anhedonia-glp1-dopamine
vida: extract claims from 2026-05-05-northwestern-agrp-neurons-semaglutide-starvation-mechanism
- Factual accuracy — The claims appear factually correct, describing a proposed mechanism for semaglutide's action and its implications for eating disorder risk, based on the provided…
vida: extract claims from 2026-05-05-npr-glp1-eating-disorders-not-well-understood
vida: extract claims from 2026-05-05-northwestern-agrp-neurons-semaglutide-starvation-mechanism
vida: extract claims from 2026-05-05-nbcnews-eating-disorders-rise-glp1-wegovy-zepbound
- Factual accuracy — The claims appear factually correct based on the provided sources, which are primarily expert opinions and case reports from NBC News.
- Intra-PR duplicates —…
vida: research 2026 05 05
- Factual accuracy — The claims in the research journal entry appear factually correct and are supported by the referenced sources, which are primarily news articles, clinical reports, and…
vida: extract claims from 2026-05-05-fda-oral-wegovy-approval-oasis4-jan2026
- Factual accuracy — The claims appear factually correct, citing specific sources and data points like aROR values and dates of FDA approval.
- Intra-PR duplicates — There are no…
vida: extract claims from 2026-05-05-nbcnews-eating-disorders-rise-glp1-wegovy-zepbound
vida: extract claims from 2026-05-05-anad-glp1-eating-disorder-guidance
- Factual accuracy — The claims appear factually correct, supported by the provided sources from NEDA and ANAD.
- Intra-PR duplicates — There are no intra-PR duplicates; the new…
vida: extract claims from 2026-05-05-fda-oral-wegovy-approval-oasis4-jan2026
vida: extract claims from 2026-05-05-anad-glp1-eating-disorder-guidance
vida: research session 2026-05-05
- Factual accuracy — The claims in the research journal entry accurately summarize the findings from the provided inbox sources, and the inbox sources themselves are archive metadata, which…
vida: research session 2026-05-05